Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Flashpoint Therapeutics
Flashpoint Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Flashpoint Therapeutics
Total Funding
$10 M
Flashpoint Therapeutics Summary
Company Summary
Overview
Flashpoint Therapeutics is a company that develops a nanotechnology platform for cancer immunotherapies. The platform creates product profiles for therapeutic candidates to increase anti-tumor immune responses.
Type
Private
Status
Active
Founded
2022
Website
https://www.flashpoint.bio/
Sectors
Healthcare
clinical research
nanotech
pharma
platform
therapy
Homepage
Linkedin
Table of Contents
Competitors
Competitors and Similar Companies
Cadrenal Therapeutics
Healthcare - Public
NeurAxon Pharma
Healthcare - Private
Pathalys Pharma
Healthcare - Private
EIP Pharma
Healthcare - Subsidiary
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top